✦ LIBER ✦

Long-term oncological outcomes of men undergoing radical prostatectomy with preoperative prostate-specific antigen <2.5 ng/ml and 2.5–4 ng/ml

✍ Scribed by Qi, Peter; Tsivian, Matvey; Abern, Michael R.; Bañez, Lionel L.; Tang, Ping; Moul, Judd W.; Polascik, Thomas J.

Book ID: 123068881
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 205 KB
Volume: 31
Category: Article
ISSN: 1078-1439
DOI: 10.1016/j.urolonc.2012.06.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term outcomes of radical prostatect

Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level ≥50 ng/mL

✍ Brant A. Inman; Judson D. Davies; Laureano J. Rangel; Eric J. Bergstralh; Eugene 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views

PREOPERATIVE SERUM PROSTATE SPECIFIC ANT

PREOPERATIVE SERUM PROSTATE SPECIFIC ANTIGEN LEVELS BETWEEN 2 AND 22 NG./ML. CORRELATE POORLY WITH POST-RADICAL PROSTATECTOMY CANCER MORPHOLOGY: PROSTATE SPECIFIC ANTIGEN CURE RATES APPEAR CONSTANT BETWEEN 2 AND 9 NG./ML.

✍ STAMEY, THOMAS A.; JOHNSTONE, IAIN M.; McNEAL, JOHN E.; LU, ARTHUR Y.; YEMOTO, C 📂 Article 📅 2002 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 169 KB

MP-16.08: Outcome of Radical Retropubic

MP-16.08: Outcome of Radical Retropubic Prostatectomy in Patients with Total Prostate-Specific Antigen Value Less Than 2.5 Ng/Ml

✍ D. Pushkar; A. Govorov; V. Diakov; J. Kosko 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Detection Rates of Nonpalpable Prostate

Detection Rates of Nonpalpable Prostate Cancer in Korean Men With Prostate-specific Antigen Levels Between 2.5 and 4.0 ng/mL

✍ Hong Seok Kim; Seong Soo Jeon; Jae Duck Choi; Wansuk Kim; Deok Hyun Han; Byong C 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 139 KB

CAN COMPLEXED PROSTATE SPECIFIC ANTIGEN

CAN COMPLEXED PROSTATE SPECIFIC ANTIGEN AND PROSTATIC VOLUME ENHANCE PROSTATE CANCER DETECTION IN MEN WITH TOTAL PROSTATE SPECIFIC ANTIGEN BETWEEN 2.5 AND 4.0 NG./ML.

✍ OKIHARA, KOJI; FRITSCHE, HERBERT A.; AYALA, ALBERTO; JOHNSTON, DENNIS A.; ALLARD 📂 Article 📅 2001 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 417 KB

Pathological Outcomes and Biochemical Pr

Pathological Outcomes and Biochemical Progression in Men With T1c Prostate Cancer Undergoing Radical Prostatectomy With Prostate Specific Antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml

✍ Makarov, Danil V.; Humphreys, Elizabeth B.; Mangold, Leslie A.; Walsh, Patrick C 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 91 KB